News and Trends 9 Jan 2020 Emergex Vaccines Secures €10M to Advance Synthetic Vaccine Development The UK biotech Emergex Vaccines has raised over €9.9M in a Series A funding round, which will allow it to progress the development of vaccines against diseases such as dengue, influenza, and Ebola to phase I clinical trials. Emergex specializes in the development of ‘set-point’ vaccines, which company CEO and co-founder Thomas Rademacher describes as […] January 9, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 29 Nov 2019 Bioplastics Consortium Granted €25M EU Funding The PEFerence consortium, coordinated by Avantium Renewable Polymers, has received reconfirmation of a €25M Horizon 2020 grant from the Bio-based Industries Joint Undertaking to develop plant-based, recyclable plastics. The grant was originally awarded in 2017 when the PEFerence consortium was under coordination of Synvina, a joint venture between Avantium and BASF. This venture was dissolved […] November 29, 2019 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Sponsored 27 Nov 2019 How to Address the Challenges of Biologics Discovery and Development The biologics industry is growing at an incredible rate. While its global market value was estimated at $236B in 2017, it is expected to rise to $310B by 2023. As key market players enter the field, competition is increasing. In recent years, the biologics industry has become more versatile and has moved from being primarily […] November 27, 2019 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 21 Nov 2019 €37.4M Invested in Azeria Therapeutics’ Cancer Treatment Program UK-based Azeria Therapeutics has raised a Series B investment round of €37.4M to fund development of novel breast cancer drugs targeting proteins called pioneer factors. The series B financing includes a €34.5M commitment from leading UK healthcare VC firm Syncona. The remainder was provided by the CRT Pioneer Fund — a specialist UK fund dedicated […] November 21, 2019 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 15 Nov 2019 UK Spinout Secures Over €3M to Develop Novel Anticoagulants LUNAC Therapeutics has spun out of the University of Leeds with €3.09M of funding from the university and the VC firm Epidarex Capital for the development of anticoagulants with a lower risk for bleeding than those currently available. The new anticoagulants will target activated factor XII, a protein which company founders Helen Philippou and Richard […] November 15, 2019 - 2 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 8 Nov 2019 EU Project Receives €15M to Bring mRNA Therapy to a Wider Audience An EU research project has launched with the aim of bringing mRNA treatments to a wider range of patients and diseases. The EXPERT – Expanding Platforms for Efficacious mRNA Therapeutics – project is a collaboration among academics and industry experts from 11 countries who will work on a novel delivery system for messenger (m)RNA therapeutics […] November 8, 2019 - 4 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Opinion 29 Oct 2019 How Culture Impacts Biotech Investment Culture influences your choices about money. This applies in normal life, but also in the business of biotech funding and if you want to build an international business, or invest in one, then you need to have some understanding of local culture. The average US citizen spent 25 times more on credit cards than the […] October 29, 2019 - 8 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Sponsored 15 May 2019 6 Tips on How to Choose the Best Software Solution for Your Biopharma Partnering Biotechnology is booming. Everyone working in the life science industry knows it and the numbers say so too. By 2025, for instance, the global biotech market is estimated to reach $727Bn. But this fast-paced environment also comes with its pitfalls. The great increase in competition leaves many companies struggling to find the necessary funds, the […] May 15, 2019 - 9 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Infographics 3 Apr 2019 Infographic: The Importance of New Biological Drug Characterization By 2023, the monoclonal antibodies market is expected to reach a staggering $130B. The potential of monoclonal antibodies and other biologic drugs is huge. They are promising treatments for severe diseases and can improve or save patients’ lives. Check out our shiny new infographic on why these biologics need to be characterized properly! Download the […] April 3, 2019 - 1 minutemin - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 25 Feb 2019 Accelerator or Incubator? What to Look for in a Biotech Startup Program Early stage biotech companies and scientists interested in commercialization need great accelerator programs, not more biotech incubators. Biotech companies and scientists who start out on the road to commercialization may need an accelerator to bring out the entrepreneurial spirit. The incubator and accelerator models are conflated all the time in biotech, much to the fury […] February 25, 2019 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 11 Dec 2018 Easy as ATCG: Commercialization of DNA as Data Storage You could be storing information in DNA sooner than you might think. Although the technology is still quite early — the first video encoded in DNA, revealed last year, was quite simple — the rate at which the cost of writing DNA is going down might make DNA data storage a reality in the coming […] December 11, 2018 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Infographics 28 Nov 2018 Infographic: The Next Big Thing in Biological Drug Delivery By the year 2022, half of the top 100 drug sales will be biologics. And with 2,700 biologics currently in development, the market will soon be booming. But there is a hitch: Most biological drugs are administered parenterally. And though this is better than nothing, it does coincide with high treatment costs and stress for […] November 28, 2018 - 1 minutemin - By External Contributor Share WhatsApp Twitter Linkedin Email